Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Series A
MODALITY
ECoG
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Paralysis/motor
TARGET USER
Patients
REGULATORY STAGE
Investigational
NeuroXess is an implantable BCI company focused on restoring communication and motor function, positioning itself in the same broad assistive category as Synchron and Precision Neuroscience. It appears to be at an earlier stage with less public visibility, making differentiation harder to assess.#
At the end of October, Shanghai-based NeuroXess announced a $98 million Series B to advance its fully implanted, wireless BCI. The company is quickly progressing towards regulatory approval in China.